These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

542 related items for PubMed ID: 17674485

  • 1. Petition to request an exemption from 100 percent identity testing of dietary ingredients: Current Good Manufacturing Practice in Manufacturing, Packaging, Labeling, or Holding Operations for Dietary Supplements. Interim final rule.
    Food and Drug Administration, HHS.
    Fed Regist; 2007 Jun 25; 72(121):34959-69. PubMed ID: 17674485
    [Abstract] [Full Text] [Related]

  • 2. Current good manufacturing practice in manufacturing, packaging, labeling, or holding operations for dietary supplements. Final rule.
    Food and Drug Administration, HHS.
    Fed Regist; 2007 Jun 25; 72(121):34751-958. PubMed ID: 17674484
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. FDA regulation of dietary supplements and requirements regarding adverse event reporting.
    Frankos VH, Street DA, O'Neill RK.
    Clin Pharmacol Ther; 2010 Feb 25; 87(2):239-44. PubMed ID: 20032973
    [Abstract] [Full Text] [Related]

  • 7. Current good manufacturing practice in manufacturing, processing, packing, or holding of drugs; revision of certain labeling controls--FDA. Final rule.
    Fed Regist; 1993 Aug 03; 58(147):41348-54. PubMed ID: 10127711
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Biological products: reporting of biological product deviations in manufacturing. Food and Drug Administration, HHS. Final rule.
    Fed Regist; 2000 Nov 07; 65(216):66621-35. PubMed ID: 11503696
    [Abstract] [Full Text] [Related]

  • 11. Current good manufacturing practice regulation and investigational new drugs. Direct final rule.
    Food and Drug Administration. HHS.
    Fed Regist; 2006 Jan 17; 71(10):2458-62. PubMed ID: 16479693
    [Abstract] [Full Text] [Related]

  • 12. Medical devices; current good manufacturing practice (CGMP) final fule; quality system regulation--FDA. Final rule.
    Fed Regist; 1996 Oct 07; 61(195):52602-62. PubMed ID: 10168287
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Amendment to the current good manufacturing practice regulations for finished pharmaceuticals. Direct final rule.
    Food and Drug Administration, HHS.
    Fed Regist; 2007 Dec 04; 72(232):68064-70. PubMed ID: 18064770
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Can claims, misleading information, and manufacturing issues regarding dietary supplements be improved in the United States?
    Gibson JE, Taylor DA.
    J Pharmacol Exp Ther; 2005 Sep 04; 314(3):939-44. PubMed ID: 15833895
    [Abstract] [Full Text] [Related]

  • 18. Establishment, maintenance, and availability of records: amendment to record availability requirements. Final rule.
    Food and Drug Administration, HHS.
    Fed Regist; 2014 Apr 04; 79(65):18799-802. PubMed ID: 24716304
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Iron-containing supplements and drugs; label warning statements and unit-dose packaging requirements; removal of regulations for unit-dose packaging requirements for dietary supplements and drugs. Final rule; removal of regulatory provisions in response to court order.
    Food and Drug Administration, HHS.
    Fed Regist; 2003 Oct 17; 68(201):59714-5. PubMed ID: 14567392
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.